Regen BioPharma, Inc.
RGBP
$0.055
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -867.30K | -927.40K | -896.50K | -829.00K | 1.16M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 29.00K | 13.90K | 9.60K | 5.30K | 900.00 |
| Total Other Non-Cash Items | 359.20K | 457.10K | 454.80K | 454.80K | 597.20K |
| Change in Net Operating Assets | -214.10K | -111.30K | -50.00K | 43.10K | -1.93M |
| Cash from Operations | -693.10K | -567.60K | -482.00K | -325.70K | -173.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 19.10K | 143.80K | 143.80K | 243.80K | 243.80K |
| Total Debt Repaid | -10.00K | -50.50K | -71.50K | -46.50K | -- |
| Issuance of Common Stock | 563.60K | 535.50K | 400.20K | 212.30K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 572.80K | 628.80K | 472.50K | 409.60K | 243.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -120.30K | 61.10K | -9.60K | 83.80K | 69.80K |